Association Between the Trajectories of the Atherogenic Index of Plasma and Prediabetes Progression to Diabetes: A Retrospective Cohort Study
XiXuan Cai,MingYing Xu,JieRu Chen,YueChun Mao,JingYu Hu,LuSha Li,JianJiang Pan,MengQi Jin,LiYing Chen
DOI: https://doi.org/10.2147/dmso.s481578
2024-12-07
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:XiXuan Cai, MingYing Xu, JieRu Chen, YueChun Mao, JingYu Hu, LuSha Li, JianJiang Pan, MengQi Jin, LiYing Chen Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310020, People's Republic of China Correspondence: LiYing Chen, Department of General Practice, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310020, People's Republic of China, Email Purpose: This study aims to analyze baseline profiles and longitudinal changes in Atherogenic Index of Plasma (AIP) among individuals with prediabetes to identify distinct AIP trajectories and assess their significance in predicting diabetes onset. Methods: This retrospective cohort study analyzed data from 8346 participants who underwent multiple general health checks. Utilizing latent class trajectory modeling and Cox proportional hazards analyses, it examined the association between the AIP index and health outcomes. Results: Over about 2 years, 2897 people progressed from prediabetes to diabetes. Individuals in the highest quartile of AIP had a higher diabetes risk compared to the lowest quartile (HR = 1.138, 95% CI1.013– 1.278). Trajectory analysis revealed three groups: low-stable, moderate-stable, and high-stable, based on AIP index. The moderate-stable group showed a 1.117-fold risk of diabetes progression (95% CI1.026– 1.217), while the high-stable group had an elevated risk (HR = 1.224, 95% CI1.059– 1.415). Conclusion: The study highlights a clear association between higher AIP index levels at baseline and an increased risk of diabetes progression. It underscores the significance of utilizing the AIP index as a predictive tool to identify those at risk, emphasizing the need for targeted preventive measures in managing diabetes progression. Keywords: retrospective cohort study, atherogenic index of plasma, prediabetes progression, diabetes Prediabetes represents a crucial stage in the progression toward type 2 diabetes (T2DM), signaling heightened risks for future diabetes, cardiovascular diseases, microvascular complications, and related conditions. 1 Despite its importance, the global prevalence of prediabetes was 7.7% in 2017, impacting approximately 374 million individuals, with projections estimating that by 2045, approximately 548 million adults will have prediabetes, accounting for 8.6% of the global adult population. 2,3 Significantly, each year, 5% to 10% of adults with prediabetes advance to diabetes, with about 70% eventually developing diabetes. 4 Hence, effective intervention for individuals with prediabetes is crucial for averting diabetes onset. Atherosclerosis, a fundamental process in cardiovascular diseases, is intricately linked to glucose dysregulation. The Atherogenic Index of Plasma (AIP), conceptualized by dobiášová et al 5 is characterized as the logarithm of the quotient of plasma triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C). It serves as a marker of lipid-related atherosclerosis, offering insights into cardiovascular risk. Previous research underscores the role of lipotoxicity in peripheral insulin resistance and dysfunction of pancreatic β-cells, key stages in T2DM pathogenesis. 6,7 Interventions targeting lipotoxicity can mitigate the natural progression of prediabetes by reducing endogenous insulin levels in patients with hypertriglyceridemia. 8 Recent observational studies reaffirm the significant association between AIP and prediabetes/diabetes onset. 9–12 Despite recognizing the connection between atherosclerosis and glucose metabolism, comprehensive studies on baseline characteristics and longitudinal AIP trajectories in prediabetes, as well as its predictive value for diabetes progression, remain sparse. This retrospective cohort study seeks to clarify the association between plasma AIP trajectories and the transition from prediabetes to diabetes. By examining baseline profiles and longitudinal AIP changes among individuals with prediabetes, we aim to delineate distinct AIP trajectories and evaluate their predictive capacity for diabetes onset. Understanding the dynamic interplay between AIP trajectories and T2DM development holds clinical significance for risk assessment and preventive strategies. The foundational clinical data utilized in this analysis were acquired from individuals undergoing health assessments Health Promotion Center of Sir Run Run Shaw Hospital, Zhejiang University, located in Hangzhou, China. The data encompass the timeframe spanning from January 2017 to December 2021. Initially, a cohort of 381,768 individuals was considered. However, after applying exclusion criteria, the following groups were excluded: (1) individua -Abstract Truncated-
endocrinology & metabolism